MBX Biosciences, Inc. financial data

Symbol
MBX on Nasdaq
Location
Carmel, IN
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2510% %
Debt-to-equity 4% %
Return On Equity -29% % 98%
Return On Assets -28% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 44,902,302 shares 34%
Common Stock, Shares, Outstanding 44,715,498 shares 34%
Entity Public Float $310,890,086 USD
Common Stock, Value, Issued $6,000 USD 20%
Weighted Average Number of Shares Outstanding, Basic 34,198,597 shares 425%
Weighted Average Number of Shares Outstanding, Diluted 34,198,597 shares 425%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $74,622,000 USD 15%
General and Administrative Expense $16,248,000 USD 63%
Operating Income (Loss) $90,870,000 USD -22%
Net Income (Loss) Attributable to Parent $80,473,000 USD -46%
Earnings Per Share, Basic 17 USD/shares 77%
Earnings Per Share, Diluted 17 USD/shares 77%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $223,125,000 USD 68%
Marketable Securities, Current $168,548,000 USD 17%
Cash, Cash Equivalents, and Short-term Investments $391,700,000 USD 41%
Other Assets, Current $882,000 USD 5.3%
Assets, Current $397,502,000 USD 41%
Property, Plant and Equipment, Net $2,004,000 USD 94%
Operating Lease, Right-of-Use Asset $520,000 USD 254%
Other Assets, Noncurrent $50,000 USD 0%
Assets $400,076,000 USD 42%
Accounts Payable, Current $3,768,000 USD -25%
Accrued Liabilities, Current $8,140,000 USD 42%
Liabilities, Current $12,062,000 USD 10%
Operating Lease, Liability, Noncurrent $469,000 USD 966%
Liabilities $12,538,000 USD 14%
Accumulated Other Comprehensive Income (Loss), Net of Tax $154,000 USD 45%
Retained Earnings (Accumulated Deficit) $202,414,000 USD -66%
Stockholders' Equity Attributable to Parent $387,538,000 USD 43%
Liabilities and Equity $400,076,000 USD 42%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $22,678,000 USD -112%
Net Cash Provided by (Used in) Financing Activities $4,000 USD -98%
Net Cash Provided by (Used in) Investing Activities $3,226,000 USD -79%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 44,715,498 shares 34%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $19,448,000 USD -497%
Deferred Tax Assets, Valuation Allowance $41,456,000 USD 92%
Deferred Tax Assets, Gross $41,642,000 USD 92%
Depreciation $273,000 USD 0%
Payments to Acquire Property, Plant, and Equipment $30,000 USD -89%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $80,447,000 USD -19%
Property, Plant and Equipment, Gross $2,614,000 USD 87%
Operating Lease, Liability, Current $154,000 USD -7.2%
Deferred Tax Assets, Operating Loss Carryforwards $14,903,000 USD 64%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $4,331,000 USD 105%
Operating Lease, Payments $200,000 USD 0%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%